← Back to Screener
SOPHiA GENETICS SA Ordinary Shares (SOPH)
Price$5.12
Favorite Metrics
Price vs S&P 500 (26W)9.18%
Price vs S&P 500 (4W)-2.56%
Market Capitalization$363.36M
All Metrics
Book Value / Share (Quarterly)$0.69
P/TBV (Annual)15.23x
Indicated Dividend (Annual)$0.00
Revenue Growth (3Y)17.56%
Cash Flow / Share (Quarterly)$-0.65
Price vs S&P 500 (YTD)5.92%
Gross Margin (TTM)67.40%
Net Profit Margin (TTM)-102.24%
EPS (TTM)$-1.17
10-Day Avg Trading Volume0.09M
EPS Excl Extra (TTM)$-1.17
Revenue Growth (5Y)22.16%
EPS (Annual)$-1.17
ROI (Annual)-71.71%
Gross Margin (Annual)67.40%
Net Profit Margin (5Y Avg)-138.16%
Cash / Share (Quarterly)$1.03
Revenue Growth QoQ (YoY)22.41%
ROA (Last FY)-48.46%
Revenue Growth TTM (YoY)18.56%
EBITD / Share (TTM)$-1.00
ROE (5Y Avg)-70.99%
Operating Margin (TTM)-91.76%
Cash Flow / Share (Annual)$-0.65
P/B Ratio7.71x
P/B Ratio (Quarterly)6.72x
Net Income / Employee (Annual)$-0
EV / Revenue (TTM)4.61x
Net Interest Coverage (TTM)-11.74x
ROA (TTM)-48.55%
EPS Incl Extra (Annual)$-1.17
Current Ratio (Annual)1.96x
Quick Ratio (Quarterly)1.69x
3-Month Avg Trading Volume0.16M
52-Week Price Return75.43%
Revenue / Employee (TTM)$0
Tangible BV / Share (Quarterly)$0.16
P/S Ratio (Annual)4.70x
Asset Turnover (Annual)0.47x
52-Week High$5.70
Operating Margin (5Y Avg)-135.05%
EPS Excl Extra (Annual)$-1.17
CapEx CAGR (5Y)21.92%
26-Week Price Return13.17%
Quick Ratio (Annual)1.72x
13-Week Price Return-1.55%
Total Debt / Equity (Annual)1.34x
Current Ratio (Quarterly)1.96x
Enterprise Value$356.091
Revenue / Share Growth (5Y)20.60%
Asset Turnover (TTM)0.47x
Revenue / Employee (Annual)$0
Inventory Turnover (Annual)4.12x
Pretax Margin (Annual)-100.28%
Cash / Share (Annual)$1.03
3-Month Return Std Dev48.66%
Gross Margin (5Y Avg)66.34%
Net Income / Employee (TTM)$-0
ROE (Last FY)-167.57%
Net Interest Coverage (Annual)-11.74x
EPS Basic Excl Extra (Annual)$-1.17
Receivables Turnover (TTM)6.89x
Total Debt / Equity (Quarterly)1.34x
EPS Incl Extra (TTM)$-1.17
Receivables Turnover (Annual)6.89x
ROI (TTM)-64.43%
P/S Ratio (TTM)4.70x
Pretax Margin (5Y Avg)-137.21%
Revenue / Share (Annual)$1.14
Tangible BV / Share (Annual)$0.30
Price vs S&P 500 (52W)45.60%
Year-to-Date Return8.57%
5-Day Price Return7.19%
EPS Normalized (Annual)$-1.17
ROA (5Y Avg)-37.18%
Net Profit Margin (Annual)-102.24%
Month-to-Date Return2.42%
Cash Flow / Share (TTM)$-0.94
EBITD / Share (Annual)$-1.00
Operating Margin (Annual)-91.76%
LT Debt / Equity (Annual)1.01x
ROI (5Y Avg)-46.69%
LT Debt / Equity (Quarterly)1.01x
EPS Basic Excl Extra (TTM)$-1.17
P/TBV (Quarterly)28.15x
P/B Ratio (Annual)6.72x
Inventory Turnover (TTM)4.12x
Pretax Margin (TTM)-100.28%
Book Value / Share (Annual)$0.69
Price vs S&P 500 (13W)-2.24%
Beta1.01x
Revenue / Share (TTM)$1.13
ROE (TTM)-116.98%
52-Week Low$2.58
Analyst Recommendations
Jan 2026
Feb 2026
Mar 2026
Apr 2026
4.30
4.30
4.30
4.30
Industry Peers — Computer Processing & Data(65)
| Symbol | P/S Ratio (TTM) | Revenue Growth TTM (YoY) | Gross Margin (TTM) | Operating Margin (TTM) | Price |
|---|---|---|---|---|---|
SOPHSOPHiA GENETICS SA Ordinary Shares | 4.70x | 18.56% | 67.40% | -91.76% | $5.12 |
ADPAutomatic Data Processing | 3.81x | 6.59% | 46.16% | 26.28% | $200.39 |
WDAYWorkday, Inc. Class A Common Stock | 3.36x | 13.09% | 75.70% | 13.47% | $124.87 |
RDDTReddit, Inc. | 13.75x | 69.40% | 91.18% | 20.07% | $162.45 |
VRSKVerisk Analytics, Inc. Common Stock | 8.00x | 6.63% | 69.88% | 43.25% | $178.31 |
TOSTToast, Inc. | 2.70x | 24.05% | 25.89% | 4.75% | $28.50 |
APLDApplied Digital Corporation Common Stock | 27.74x | 128.91% | 27.86% | -43.76% | $30.09 |
QBTSD-Wave Quantum Inc. | 313.09x | 178.54% | 82.59% | -408.22% | $21.52 |
PEGAPegasystems Inc | 4.20x | 16.61% | 75.86% | 15.06% | $43.28 |
CARGCarGurus, Inc. Class A Common Stock | 3.80x | 1.41% | 92.78% | 26.95% | $36.21 |
LIFLife360, Inc. Common Stock | 6.98x | 31.76% | 77.81% | 3.85% | $46.05 |
About
Sophia Genetics SA is a healthcare technology company that provides a cloud-based SaaS platform for analyzing complex diagnostic data and generating clinical insights. The platform enables data-driven medicine across multiple diagnostic modalities, serving healthcare providers and life sciences researchers. Headquartered in Switzerland, the company maintains operations in France, the United States, and Brazil.